About GeniPhys
GeniPhys is a Healthcare company based in Zionsville (United States) founded in 2014. Collagen polymers are developed for tissue regeneration applications. GeniPhys has raised $13.47 million across 7 funding rounds from investors including National Science Foundation, Pier 70 Ventures and Elevate Ventures. GeniPhys offers products and services including Collymer Technology. Its focus areas include Life Sciences, Regenerative Medicine, Biomaterials and Scaffolds. Its legal entity is GeniPhys, Inc. Its competitors include Organogenesis, Sofregen and BioTissue; 3 of its 3 listed competitors have raised funding.
Company details
GeniPhys was founded in 2014 and is based in Zionsville, United States. Collagen polymers are developed within the biotechnology sector for tissue regeneration. Collymer, a polymerizable collagen-based scaffold, is provided to facilitate tissue restoration. This material is applied in areas such as cartilage replacement, vascular grafts, heart valve replacement, and related medical uses. Operations focus on advancing regenerative medicine solutions.
- Headquarters Zionsville, United States
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website geniphys.com
- Legal Name Geniphys, Inc.
- Total Equity Funding$13.47M (USD)
in 7 rounds
- Latest Funding Round$3M (USD), Series A
Jan 2026
- InvestorsNational Science Foundation
& 3 more
Products & Services of GeniPhys
GeniPhys offers a comprehensive portfolio of products and services, including Collymer Technology.
Polymerizable collagen for tissue regeneration and restoration applications.
Funding Insights of GeniPhys
GeniPhys has successfully raised a total of $13.47M across 7 strategic funding rounds. The most recent funding activity was a Series A round of $3 million completed in January 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $13.47M
- Total Rounds 7
- Last Round Series A — $3M
- First Round $20,000
(May 2015)
- Investors Count 4
All 7 funding rounds of GeniPhys with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2026 | $3M | Series A | – | – | – |
| Oct 2024 | $500,000 | Grant | – | – | |
| Mar 2023 | $6M | Series A | – | – | |
| Nov 2022 | $4.45M | Series A | – | – | – |
| Feb 2022 | $974,349 | Grant | – | – | |
| Jul 2019 | $224,873 | Grant | – | – | |
| May 2015 | $20,000 | Seed | – | – |
4 investors in total: 4 institutional.
Investors in GeniPhys
GeniPhys has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include National Science Foundation, Pier 70 Ventures and Elevate Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| pier70ventures.com | ||||
Early-stage investments are made in diverse sectors by the firm. | elevateventures.com | Indianapolis, United States | ||
Support for technology commercialization and startup development is provided. | purduefoundry.com | West Lafayette, United States | ||
A government-backed foundation providing seed-stage investments to support small businesses. | 1950 | nsf.gov | Arlington, United States |
Investor details for GeniPhys
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of GeniPhys
7 people are tracked at GeniPhys (3 in leadership, 3 in board & advisors, 1 in team).
| Name | Role | Group |
|---|---|---|
Sherry Harbin | Founder & CSO | Leadership |
Andrew Eibling | President & CEO | Leadership |
Mike Hoffa | COO | Leadership |
Matthew Neff | Chairman | Board & advisors |
Shaun Hawkins | Director | Board & advisors |
John Deford | Director | Board & advisors |
TJ Puls, PhD | Product Development Manager | Team |
Complete people profiles for GeniPhys
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of GeniPhys
3 dated milestones of GeniPhys across 12 years, from founding to its latest funding, stage changes and deals.
- Founded GeniPhys is founded.
- Funding First funding round of $20K.
- Funding Latest funding round, Series A, of $3.0M.
Competitors of GeniPhys
GeniPhys has 3 listed competitors in our database, 3 of them funded. They include Organogenesis, Sofregen and BioTissue.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| organogenesis.com | 1985 | Canton, United States | $30M | 856 | Regenerative therapies for wound care are developed and commercialized. | |
| sofregen.com | 2014 | Medford, United States | $17.8M | 8 | Silk-derived biomaterials are developed for soft tissue repair in surgery. | |
| biotissue.com | 2001 | Miami, United States | $110.04M | 234 | Regenerative biologic therapies for eye care are developed and provided. |
Detailed competitors of GeniPhys
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of GeniPhys
The website of GeniPhys (geniphys.com) receives about 1.3K visits a month.
- Monthly visits1.3K
▼ 8.4% vs previous month
Top companies in Wound Care
3 companies that operate in the same segment as GeniPhys (Wound Care) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Nanotech-based wound care products are developed and provided. | 2010 | Madison, Wisconsin, United States | USD 22.7 M | 35 | ||
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics | 1985 | Marietta, Georgia, United States | USD 418.63 M | 837 | ||
Developer of hemostatic products for wound care | 2010 | New York, New York, United States | USD 113.35 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Geniphys
Complete news archive for GeniPhys
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about GeniPhys
GeniPhys was founded in 2014 and raised its 1st funding round 1 year after it was founded.
GeniPhys is headquartered in Zionsville, United States. It is registered at Zionsville, Indiana, United States.
GeniPhys is a funded company, having raised a total of $13.47M across 7 funding rounds to date. The company's 1st funding round was a Seed of $20K, raised on May 2015.
GeniPhys was founded in 2014 and is based in Zionsville, United States. Collagen polymers are developed within the biotechnology sector for tissue regeneration. Collymer, a polymerizable collagen-based scaffold, is provided to facilitate tissue restoration. This material is applied in areas such as cartilage replacement, vascular grafts, heart valve replacement, and related medical uses. Operations focus on advancing regenerative medicine solutions.
GeniPhys's top competitors include Organogenesis, Sofregen and BioTissue.
GeniPhys offers Collymer Technology.
GeniPhys has 4 investors. Key investors include National Science Foundation, Pier 70 Ventures, Elevate Ventures, and Purdue Innovates.
GeniPhys operates through Geniphys, Inc..